Symbiotries

Symbiotries

Closed: Oct. 2018

About this raise: Symbiotries is accounting software for real people. With their technology, you don’t need an accounting background to ensure you’re maximizing your dollars. The ywant to “empower small businesses to take control of their financial futures,” and their plan is to develop a cloud-based and desktop version of their accounting software package for both Macs and PCs. Right now, Symbiotries is in the development phase. In November 2017, they constructed the wireframe and started building the software, and they anticipate a November 2019 release.

Expand

Investment Overview

Not Funded: $3,056

Deal Terms

Total Commitments ($USD)

Platform
StartEngine
Start Date
07/23/2018
Close Date
10/23/2018
Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$250

Security Type

Equity - Preferred

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$4,397,500

Company & Team

Company

Year Founded
2015
Industry
Business Services, Software, & Applications
Tech Sector
Location
Wexford, Pennsylvania
Company Website
Visit Website

Team

Employees
15

Financials

Financials are not currently available for this company. This may occur if the company is still Testing the Waters, is a Regulation D offering, or if the financials are still under review and being confirmed by our team. For Reg CF and Reg A+ raises, please check back later.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
10/23/2018 StartEngine $4,397,500 $3,056 Equity - Preferred Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Symbiotries on StartEngine
Platform: StartEngine
Security Type: Equity - Preferred
Valuation: $4,397,500
Price per Share: $1.00

Follow company

Follow Symbiotries on StartEngine

Buy Symbiotries's Deal Report

Warning: according to the close date for this deal, Symbiotries may no longer be accepting investments.

Symbiotries Deal Report

Get Kingscrowd's comprehensive report on Symbiotries including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Symbiotries is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Symbiotries deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge